M. Bonay et al., ACTIVATION OF T-CELLS THROUGH AN ANTIGEN-INDEPENDENT ALTERNATIVE PATHWAY INDUCES PRECOCIOUS SENSITIVITY TO FAS-INDUCED APOPTOSIS, Immunology letters, 59(2), 1997, pp. 107-113
Autoreactive T-cells can be activated inadvertently during immune resp
onses through antigen-independent pathways. It has been suggested that
Fas/Fas-ligand interactions may play a role in eliminating these cell
s, but the extent that cells activated through such alternative pathwa
ys are sensitive to Fas-induced apoptosis has not been extensively eva
luated. Proliferation of peripheral blood T-cells from normal individu
als activated for 4 days with PHA or PMA + ionophore was not influence
d by the presence of anti-Fas antibody. When the same cells were activ
ated with soluble factors produced by previously activated T-cells (ly
mphostimulatory activity), anti-Fas antibodies inhibited thymidine inc
orporation by 74+/-4%. The presence of typical morphological changes a
nd oligonucleosomal fragmentation of DNA indicated that the reduced pr
oliferation resulted from apoptotic death of the lymphoblasts. Fas-sen
sitivity of T-cells activated by lymphostimulatory activity was first
detectable 4 days after activation, and at 5 days the majority of lymp
hoblasts bad become sensitive to Fas, whereas no evidence of sensitivi
ty to Fas was observed for lymphoblasts generated by PHA or PMA + iono
phore during the first 5 days of culture. Incubation of cells activate
d with PHA or PMA+ionophore in the presence of IL-2 at concentrations
10-fold higher than that present in lymphostimulatory activity did not
induce early sensitivity to Fas, indicating that exposure to IL-2 cou
ld not explain the precocious development of sensitivity to Fas seen f
ollowing activation by lymphostimulatory activity. These studies demon
strate that T-cells activated through an antigen-independent 'alternat
ive' pathway develop precocious sensitivity to Fas-induced apoptosis,
which may be important in permitting the elimination of autoreactive b
ystander cells activated in the course of immune responses. (C) 1997 E
lsevier Science B.V.